Here, it was found that NR4A3 was significantly lower expressed in patients with bladder cancer, whereas JorA could increase NR4A3 expression in bladder cancer T24 cells, suggesting that JorA may exert its tumor suppressor effect through the regulation of NR4A3. Here, NR4A3 is linked to urinary bladder cancer.